MDT

87.13

-1.01%↓

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

Inicio・Lista de Acciones・Gossamer Bio Inc

Gossamer Bio Inc

Cerrado

SectorSanidad

0.44 4.76

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

0.41

Máximo

0.46

Métricas clave
By Trading Economics
Ingresos	983K -47M
Ventas	505K 14M
Margen de beneficios	-342.329
Empleados	161
EBITDA	-346K -46M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+1000% upside

Dividendos
By Dow Jones
Próximas Ganancias	14 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-12M 94M
Apertura anterior	-4.32
Cierre anterior	0.44

Noticias sobre sentimiento de mercado

By Acuity

76%

24%

327 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

1.06 / 1.23 Soporte y Resistencia

Gossamer Bio Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 abr 2026, 23:36 UTC

Adquisiciones, fusiones, absorciones

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion -- Update

14 abr 2026, 23:24 UTC

Acciones populares

Stocks to Watch: Gloo, Broadcom, GitLab

14 abr 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion

14 abr 2026, 21:32 UTC

Principales Movimientos del Mercado

GitLab Shares Rise on Expanded Google Cloud Collaboration

14 abr 2026, 23:54 UTC

Charlas de Mercado

Nikkei May Rise as Fears About Energy Shortage Ease -- Market Talk

14 abr 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Lower on Possible Technical Correction -- Market Talk

14 abr 2026, 22:54 UTC

Ganancias

BRP: Amendment Mainly Leads to 25% Tariff on Total Value of Imported Snowmobiles and Majority of ORV Models, Replacing Previous 50% Tariff on Applicable Metal Content Only >DOO.T

14 abr 2026, 22:54 UTC

Ganancias

BRP: Suspending Guidance Following Amendment of Section 232 Tariffs on Steel, Aluminum and Copper Imports Into U.S., Which Came Into Effect on April 6 >DOO.T

14 abr 2026, 22:54 UTC

Ganancias

BRP: Currently Estimates Potential Incremental Tariff Cost Related to This Amendment in Excess of $500M for Remainder of Yr >DOO.T

14 abr 2026, 22:54 UTC

Ganancias

BRP: Suspends FY27 Guidance Due to Changes to U.S. Tariff Environment

14 abr 2026, 22:17 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Targets Deal Completion Toward End of 3Q

14 abr 2026, 22:17 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Acquisition Diversifies Portfolio; Met Coal Share to Rise to 22%

14 abr 2026, 22:17 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Asset 'Strong Strategic Fit'; to Positively Add Production, Cash Flow

14 abr 2026, 22:16 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Intends to Fund Acquisition With Cash, 5-Year Loan Facility

14 abr 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Contingent Consideration Linked to Average Annual Prices For 5 Years

14 abr 2026, 22:14 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Deal Includes Contingent Cash Consideration Up to $550 Million

14 abr 2026, 22:13 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: Deal Includes $1.85 Billion Upfront Consideration

14 abr 2026, 22:12 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: To Buy Kestrel Stake From EMR Capital, Adaro Capital

14 abr 2026, 22:12 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: To Buy Kestrel Stake For Up to $2.4 Billion

14 abr 2026, 22:10 UTC

Adquisiciones, fusiones, absorciones

Yancoal Australia: to Acquire 80% Interest in Kestrel Coal Mine

14 abr 2026, 20:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

14 abr 2026, 20:33 UTC

Adquisiciones, fusiones, absorciones

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 abr 2026, 20:32 UTC

Acciones populares

Stocks to Watch: JPMorgan, American Airlines, LVMH, BlackRock -- WSJ

14 abr 2026, 19:59 UTC

Adquisiciones, fusiones, absorciones

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 abr 2026, 19:38 UTC

Ganancias

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 abr 2026, 19:27 UTC

Charlas de Mercado

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

14 abr 2026, 19:21 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Retreat on Hopes for U.S.-Iran Peace Talks -- Market Talk

14 abr 2026, 19:09 UTC

Adquisiciones, fusiones, absorciones

Apple and Amazon Partner on Satellite Deal. Why It Makes Sense. -- Barrons.com

14 abr 2026, 18:30 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 abr 2026, 18:30 UTC

Charlas de Mercado

Treasury Yields, Dollar Fall as Markets Price Higher Odds of Fed Cuts -- Market Talk

Comparación entre iguales

Cambio de precio

Gossamer Bio Inc previsión

Precio Objetivo

By TipRanks

1000% repunte

Estimación a 12 Meses

Media 4.4 USD 1000%

Máximo 15 USD

Mínimo 0.3 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Gossamer Bio Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Gossamer Bio Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.06 / 1.23Soporte y Resistencia

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentimiento

By Acuity

327 / 348 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.